Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

NEXGEL, Inc.

NXGLNASDAQ
Healthcare
Medical - Instruments & Supplies
$1.20
$-0.05(-4.00%)
U.S. Market is Open • 14:28

NEXGEL, Inc. Fundamental Analysis

NEXGEL, Inc. (NXGL) shows weak financial fundamentals with a PE ratio of -3.38, profit margin of -24.69%, and ROE of -55.33%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.12%.

Key Strengths

PEG Ratio-0.46
Current Ratio1.69

Areas of Concern

ROE-55.33%
Operating Margin-25.54%
We analyze NXGL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -31.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-31.8/100

We analyze NXGL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NXGL struggles to generate sufficient returns from assets.

ROA > 10%
-24.78%

Valuation Score

Excellent

NXGL trades at attractive valuation levels.

PE < 25
-3.38
PEG Ratio < 2
-0.46

Growth Score

Moderate

NXGL shows steady but slowing expansion.

Revenue Growth > 5%
1.12%
EPS Growth > 10%
10.71%

Financial Health Score

Excellent

NXGL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.60
Current Ratio > 1
1.69

Profitability Score

Weak

NXGL struggles to sustain strong margins.

ROE > 15%
-5532.88%
Net Margin ≥ 15%
-24.69%
Positive Free Cash Flow
No

Key Financial Metrics

Is NXGL Expensive or Cheap?

P/E Ratio

NXGL trades at -3.38 times earnings. This suggests potential undervaluation.

-3.38

PEG Ratio

When adjusting for growth, NXGL's PEG of -0.46 indicates potential undervaluation.

-0.46

Price to Book

The market values NEXGEL, Inc. at 1.88 times its book value. This may indicate undervaluation.

1.88

EV/EBITDA

Enterprise value stands at -4.85 times EBITDA. This is generally considered low.

-4.85

How Well Does NXGL Make Money?

Net Profit Margin

For every $100 in sales, NEXGEL, Inc. keeps $-24.69 as profit after all expenses.

-24.69%

Operating Margin

Core operations generate -25.54 in profit for every $100 in revenue, before interest and taxes.

-25.54%

ROE

Management delivers $-55.33 in profit for every $100 of shareholder equity.

-55.33%

ROA

NEXGEL, Inc. generates $-24.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

-24.78%

Following the Money - Real Cash Generation

Operating Cash Flow

NEXGEL, Inc. generates limited operating cash flow of $-3.28M, signaling weaker underlying cash strength.

$-3.28M

Free Cash Flow

NEXGEL, Inc. generates weak or negative free cash flow of $-3.41M, restricting financial flexibility.

$-3.41M

FCF Per Share

Each share generates $-0.32 in free cash annually.

$-0.32

FCF Yield

NXGL converts -19.61% of its market value into free cash.

-19.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.38

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.46

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.60

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.55

vs 25 benchmark

ROA

Return on assets percentage

-0.25

vs 25 benchmark

ROCE

Return on capital employed

-0.36

vs 25 benchmark

How NXGL Stacks Against Its Sector Peers

MetricNXGL ValueSector AveragePerformance
P/E Ratio-3.3829.43 Better (Cheaper)
ROE-55.33%800.00% Weak
Net Margin-24.69%-20145.00% (disorted) Weak
Debt/Equity0.600.30 Weak (High Leverage)
Current Ratio1.694.64 Neutral
ROA-24.78%-17936.00% (disorted) Weak

NXGL outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NEXGEL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

935.58%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-45.82%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-82.19%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ